Nuria Osés Múgica

Director/Board Member at Cytognos SLU

Consumer Services

Finance

Health Technology

Profile

Nuria Osés Múgica is currently a Partner at GED Iberian Private Equity SGEIC SA since 2008 and a Member of the Board at Cytognos SLU since 2018.
She graduated from Instituto de Empresa SL in 2007 and completed her undergraduate degree from the University of Navarra in 1993.

Nuria Osés Múgica active positions

Companies	Position	Start
Cytognos SLU Cytognos SLU Medical SpecialtiesHealth Technology Cytognos SL is a biotechnology company. It is engaged in the developing and manufacturing reagents, software and techniques to provide solutions in flow cytometry offering monoclonal antibodies and kits, absolute counting systems, diagnostics assays, protocols and consulting services. The company was founded on November 8, 1996 and is headquartered in Santa Marta de Tormes, Spain.	Director/Board Member	30/06/2018
GED Iberian Private Equity SGEIC SA GED Iberian Private Equity SGEIC SA Investment ManagersFinance GED Iberian Private Equity SGEIC SA (GED) is the private equity and venture capital arm of GED Group headquartered in Madrid, Spain. The firm was founded in 1996.	Private Equity Investor	31/12/2007

All active positions of Nuria Osés Múgica

Training of Nuria Osés Múgica

Instituto de Empresa SL	Graduate Degree
University of Navarra	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nuria Osés Múgica's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
GED Iberian Private Equity SGEIC SA GED Iberian Private Equity SGEIC SA Investment ManagersFinance GED Iberian Private Equity SGEIC SA (GED) is the private equity and venture capital arm of GED Group headquartered in Madrid, Spain. The firm was founded in 1996.	Finance
Cytognos SLU Cytognos SLU Medical SpecialtiesHealth Technology Cytognos SL is a biotechnology company. It is engaged in the developing and manufacturing reagents, software and techniques to provide solutions in flow cytometry offering monoclonal antibodies and kits, absolute counting systems, diagnostics assays, protocols and consulting services. The company was founded on November 8, 1996 and is headquartered in Santa Marta de Tormes, Spain.	Health Technology